Prostatis Group’s Boeing BA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,025
Closed -$223K 168
2025
Q4
$223K Sell
1,025
-4,622
-82% -$951K 0.05% 158
2025
Q3
$1.22M Buy
5,647
+663
+13% +$149K 0.31% 68
2025
Q2
$1.04M Sell
4,984
-2,366
-32% -$447K 0.3% 70
2025
Q1
$1.25M Sell
7,350
-746
-9% -$129K 0.4% 55
2024
Q4
$1.43M Buy
8,096
+1,531
+23% +$240K 0.42% 56
2024
Q3
$998K Buy
6,565
+716
+12% +$123K 0.33% 66
2024
Q2
$1.08M Buy
+5,849
New +$1.04M 0.38% 60
2024
Q1
Sell
-823
Closed -$214K 138
2023
Q4
$214K Buy
+823
New +$176K 0.09% 123
2023
Q3
Sell
-608,717
Closed -$730K 117
2023
Q2
$730K Buy
608,717
+605,196
+17,188% +$126M 0.34% 64
2023
Q1
$743K Buy
+3,521
New +$732K 0.39% 58

Other funds holding BA

Prostatis Group's BA Position: Q1 2026 in Review

Prostatis Group sold out of Boeing (BA) in Q1 2026, closing a stake of 1,025 shares — an estimated $223K sold.

Prostatis Group first reported a position in BA in Q1 2023 and held it in 10 quarters. The position peaked at $1.43M in Q4 2024. 2,523 funds tracked by Wall St. Rank hold BA as of Q1 2026.

  • Prostatis Group reported no remaining Boeing position as of Q1 2026 after selling out during the quarter.
  • Prostatis Group sold 1,025 Boeing shares in Q1 2026, an estimated $223K.
  • Prostatis Group first reported a position in Boeing in Q1 2023 and held it in 10 quarters.
  • Prostatis Group's Boeing position peaked at $1.43M in Q4 2024.
  • 2,523 funds tracked by Wall St. Rank held Boeing as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.